Intra-patient and inter-metastasis heterogeneity of HER2-low status in metastatic breast cancer-Reference-Cited by-同舟云学术

Intra-patient and inter-metastasis heterogeneity of HER2-low status in metastatic breast cancer

Published:2023-07 Issue: Volume:188 Page:152-160
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Geukens Tatjana^ORCID,De Schepper Maxim^ORCID,Richard François^ORCID,Maetens Marion,Van Baelen Karen^ORCID,Mahdami Amena^ORCID,Nguyen Ha-Linh^ORCID,Isnaldi Edoardo,Leduc Sophia,Pabba Anirudh^ORCID,Zels Gitte,Mertens Freya^ORCID,Vander Borght Sara,Smeets Ann^ORCID,Nevelsteen Ines,Punie Kevin^ORCID,Neven Patrick,Wildiers Hans^ORCID,Van Den Bogaert Wouter,Floris Giuseppe,Desmedt Christine^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference29 articles.

1. Trastuzumab deruxtecan in previously treated HER2-low advanced breast cancer;Modi;N Eng J Med,2022

2. Abstract HER2-18 determination of HER2-low status in tumors of patients with unresectable and/or metastatic breast cancer in DESTINY-Breast04. San Antonio Breast Cancer Symposium 2022;Prat,2022

3. HER2-low-positive breast cancer: evolution from primary tumor to residual disease after neoadjuvant treatment;Miglietta;NPJ Breast Cancer,2022

4. Evolution of HER2-low expression from primary to recurrent breast cancer;Miglietta;NPJ Breast Cancer,2021

5. Evolution of low HER2 expression between early and advanced-stage breast cancer;Tarantino;Eur J Cancer,2022

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Whole-Body HER2 Heterogeneity Identified on HER2 PET in HER2-Negative, -Low, and -Positive Metastatic Breast Cancer;Journal of Nuclear Medicine;2024-09-05

2. A population-based study on trajectories of HER2 status during neoadjuvant chemotherapy for early breast cancer and metastatic progression;British Journal of Cancer;2024-06-28

3. Characterization of HER2‐low breast cancer in young women with germline BRCA1/2 pathogenetic variants: Results of a large international retrospective cohort study;Cancer;2024-05-16

4. Rapid autopsies to enhance metastatic research: the UPTIDER post-mortem tissue donation program;npj Breast Cancer;2024-04-24

5. Global post-mortem tissue donation programmes to accelerate cancer research;Nature Reviews Cancer;2024-04-08